Home » Topics » BioWorld Science

BioWorld Science
RSS

NK problems facilitate bnAbs in HIV

Oct. 2, 2018

Interferon, protease contribute to post-viral bacterial infections

Oct. 2, 2018

HGPS and the heart

Oct. 2, 2018

Neuraly enrolling participants in phase I study of NLY-01

Oct. 2, 2018

NEAT1 found as new therapeutic target for occlusive vascular diseases

Oct. 1, 2018

CaSR found as a novel therapeutic target for pulmonary fibrosis

Oct. 1, 2018

VEGF-D, MMP-2 and MMP-7 biomarkers in lymphangioleiomyomatosis and tuberous sclerosis complex

Oct. 1, 2018

AvroBio updates gene therapy programs in Gaucher's disease and Fabry disease

Oct. 1, 2018

FDA grants accelerated approval to Arikayce for MAC lung disease

Oct. 1, 2018

Innovent cleared to conduct clinical trials of IBI-188

Oct. 1, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.